Etavopivat is a potent, selective, and orally active erythrocyte pyruvate kinase (PKR) activator. Etavopivat has potent antisickling effects that can be used in studies of sickle cell disease and other haemoglobinopathies[1][2].
Molecular Weight:
457.50
Purity:
98.70
CAS Number:
[2245053-57-8]
Formula:
C22H23N3O6S
Target:
Pyruvate Kinase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted